ArticleInflammopharmacology2026
Ameliorative effects of Mucuna imbricata on inflammation and oxidative stress in a rat edema model.
Article in Inflammopharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Plants of the genus Mucuna have ethnomedicinal importance, several pharmacological activities along with its higher L-DOPA content as an anti-parkinson's drug. This study demonstrated the sub-acute lethality and anti-inflammatory potential of water extracts of Mucuna imbricata seed using in vivo carrageenan induced inflammation in the rat paw edema model. Sub-acute toxicity of water extract of M. imbricata, upto the concentration of 2000 mg/ Kg BW exhibited no such substantial alterations in hematological, biochemical, histological and behavioral parameters. The obtained results indicate that the extracts possesses significant restorastion of anti-inflammatory activity, which was found to be dose-dependent in carrageenan intoxicated female rats. In vivo anti-inflammatory potential of M imbricata seed extract showed significant reduction in the swelling after 5-6 h at doses of 250 and 500 mg/kg. Paw edema was measured with a digital vernier caliper and a cold sensitivity experiment, tested extracts showed positively significant activity. In this study, subplantar injection of carrageenan induced the production of free radicals, which caused oxidative damage and lead to drop in GSH levels and the activity of the antioxidant enzyme catalase, as along with an increase in lipid peroxidation. Gene expression analysis reveled TNF-α, IL-1β, IL-6, iNOX-2 and MCP-1-50 genes were upregulated and IL-10 was downregulated in carrageenan induced rats. However M. imbricata extract restored the levels of anti-inflammatory and pro-inflammatory cytokine (such as IL-1β, IL-6, and TNF-α) expression, respectively. This study suggested that M. imbricata is the potential candidate to develop novel anti-inflammatory drug.
Indexed as
Identifiers
41974981What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.